On January 17, 2018, Evofem Biosciences, Inc. (NasdaqCM:EVFM) closed the transaction. The transaction saw participation from returning investor Invesco Ltd. (NYSE:IVZ).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0109 USD | +4.31% | +9.00% | -82.97% |
07-17 | Aditxt Soars After Amendment of Evofem Merger Terms | MT |
07-17 | Top Premarket Gainers | MT |
1st Jan change | Capi. | |
---|---|---|
-82.97% | 968K | |
+55.35% | 815B | |
+31.64% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+15.51% | 247B | |
+16.72% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. announced that it has received $20 million in funding from Invesco Ltd.